| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |